Treatment of gentamicin-resistant Klebsiella urinary tract infections with cephradine, augmentin, cefuroxime and amikacin.
D000328:Adult; D000368:Aged; D000583:Amikacin / Q000627:therapeutic use; D000658:Amoxicillin / Q000627:therapeutic use; D019980:Amoxicillin-Potassium Clavulanate Combination; D002444:Cefuroxime / Q000627:therapeutic use; D002515:Cephradine / Q000627:therapeutic use; D002969:Clavulanic Acids / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004338:Drug Combinations; D005260:Female; D005839:Gentamicins / Q000494:pharmacology*; D006801:Humans; D007709:Klebsiella / Q000187:drug effects; D007710:Klebsiella Infections / Q000188:drug therapy*; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D010403:Penicillin Resistance; D014552:Urinary Tract Infections / Q000188:drug therapy*
D002969:Clavulanic Acids; D004338:Drug Combinations; D005839:Gentamicins; D019980:Amoxicillin-Potassium Clavulanate Combination; D000658:Amoxicillin; D000583:Amikacin; D002515:Cephradine; D002444:Cefuroxime